Search results for DJ-1

Park7 / DJ-1 antibody [1B11], Genetex, GTX53757

DJ-1/PARK7 Rabbit mAb, ABclonal, A19097

DJ-1/PARK7 Rabbit pAb- ABclonal, ABclonal, A18580

DJ-1 (D21E11) Rabbit Monoclonal Antibody#5560, Cell Signaling Technology (CST), 5560

DJ-1 (D21E11) Rabbit Monoclonal Antibody detects endogenous levels of total DJ-1 protein. This antibody is recommended to detect human samples but may also detect mouse and rat samples weakly.

DJ-1 (D29E5) Rabbit Monoclonal Antibody#5933, Cell Signaling Technology (CST), 5933

DJ-1 (D29E5) Rabbit Monoclonal Antibody recognizes endogenous levels of total DJ-1 protein.

DJ-1 (E9T6J) Mouse Monoclonal Antibody#35743, Cell Signaling Technology (CST), 35743

DJ-1 (E9T6J) Mouse Monoclonal Antibody recognizes endogenous levels of total DJ-1 protein.

[KO Validated] DJ-1/PARK7 Rabbit pAb- ABclonal, ABclonal, A0987

DJ-1 (D29E5) Rabbit Monoclonal Antibody (HRP Conjugate)#88652, Cell Signaling Technology (CST), 88652

DJ-1 (D29E5) Rabbit Monoclonal Antibody (HRP Conjugate) recognizes endogenous levels of total DJ-1 protein.

Protein DJ-1 (DJ-1) Antibody, Abbexa, abx013059

Rabbit polyclonal antibody against DJ-1 protein. Immunogen region is Internal.

Protein DJ-1 (DJ-1) Antibody, Abbexa, abx032825

Park 7 acts as positive regulator of androgen receptor-dependent transcription, and may function as redox-sensitive chaperone and as sensor for oxidative stress, as well as preventing aggregation of SNCA. This protein has been shown to protect neurons against oxidative stress and cell death, and to play a role in fertilization. Park7 is detected in tau inclusions in brains from neurodegenerative disease patients, and is generally highly expressed in pancreas, kidney, skeletal muscle, liver, testis and heart, with detectable levels in placenta, brain, astrocytes, Sertoli cells, spermatogonia, spermatids and spermatozoa. Defects in Park7 are the cause of autosomal recessive early-onset Parkinson disease 7 (PARK7), a form of Parkinson disease characterized by onset before 40 years, slow progression and initial good response to levodopa.